التداخل بين ريتليسيتينيب والتبغ والتدخين

In this study, current or past smokers had an additional increased risk of overall malignancies.

Patients who are current or past smokers are at additional increased risk.

Consider the benefits and risks for the individual patient prior to initiating or continuing therapy with LITFULO, particularly in patients who are current or past smokers and patients with other cardiovascular risk factors.

A higher rate of lung cancers was observed in current or past smokers treated with the JAK inhibitor compared to those treated with TNF blockers.